|
Current News Index News Archives View Zinc Products View Cold Remedy Products View Children's Cold Remedies |
Zinc Lozenges Get a Thumbs-Up For Treating the Common Cold By Donald J. Brown, ND Healthnotes Newswire (February 1, 2001)—Fighting the symptoms of a common cold is a winter ritual and is also the leading cause of doctor visits and missed school days in the United States. And along with the discomfort and frustration of enduring sneezing, a scratchy throat, and a runny nose, no known cure is available for a cold. However, clinical trials, including one published in the Annals of Internal Medicine, conclude that zinc acetate lozenges may reduce the duration of cold symptoms.1 The placebo-controlled trial examined the effect of zinc acetate lozenges on the duration of the common cold in 50 adult volunteers from Wayne State University in Detroit, Michigan. At the onset of cold symptoms, volunteers were randomly chosen to take a lozenge containing either 12.8 mg of zinc or a placebo. This was repeated every 2 to 3 hours while awake as long as the cold symptoms lasted. The researchers found that people taking zinc acetate lozenges had a significant decrease in the severity of cold symptoms, such as sore throat, runny nose, nasal drainage, cough, muscle aches, and headache, compared with those taking placebo. In addition, people taking zinc recovered from their cold in an average of 4.5 days compared with 8 days for the placebo group. Over the duration of the study, volunteers taking zinc had an average intake of about 80 mg of the trace element per day. While there were no side effects reported in the placebo group, dry mouth and constipation were reported in the zinc group. Ten previous double-blind trials of zinc’s effect on cold symptoms have netted five positive 2 3 4 5 6 and five negative outcomes.7 8 9 10 11 The researchers of the current study suggest that the negative results may have been due to the daily amount of zinc being too low and to the type of zinc used in the lozenges. While short-term (about 4 to 6 days) use of zinc acetate lozenges appears to shorten the duration and severity of the common cold, it’s important to remember that several weeks of high-dose zinc may lead to a deficiency in copper. People taking zinc for more than a couple of weeks are advised to add some copper (about 1 mg per day for every 10–30 mg of zinc) to their daily supplement regimen. References1. Prasad AS, Fitzgerald JT, Bao B, et al. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. Ann Intern Med 2000;133:245–52. 2. Petrus EJ, Lawson KA, Bucci LR, Blum K. Randomized, double-masked, placebo-controlled clinical study of the effectiveness of zinc acetate lozenges on common cold symptoms in allergy-tested subjects. Curr Ther Res 1998;59:595–607. 3. Al-Nakib W, Higgins PG, Barrow I, et al. Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. J Antimicrobial Chemotherapy 1987;20:893–901. 4. Eby G, Davis DR, Halcomb WW. Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study. Antimicrobial Agents Chemotherapy 1984;25:20–4. 5. Godfrey JC, Conant Sloane B, Smith DS, et al. Zinc gluconate and the common cold: a controlled clinical study. J Int Med Res 1992;20:234–46. 6. Mossad SB, Macknin ML, Medendorp SV, Mason P. Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study. Ann Intern Med 1996;125:81–8. 7. Weismann K, Jakobsen JP, Weismann JE, et al. Zinc gluconate lozenges for common cold. A double-blind clinical trial. Dan Med Bull 1990;37:279–81. 8. Macknin ML, Piedmonte M, Calendine C, et al. Zinc gluconate lozenges for treating the common cold in children. A randomized controlled trial. JAMA 1998;279:1962–7. 9. Farr BM, Conner EM, Betts RF, et al. Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus cold. Antimoicrob Agents Chemother 1987;31:1183–7. 10. Douglas RM, Miles HB, Moore BW, et al. Failure of effervescent zinc acetate lozenges to alter the course of upper respiratory tract infection of Australian adults. Antimoicrob Agents Chemother 1987;33:1263–5. 11. Smith DS, Helzner EC, Nuttal CE, et al. Failure of zinc gluconate in treatment of acute upper respiratory tract infections. Antimoicrob Agents Chemother 1989;33:8. Donald J. Brown, ND, is a naturopathic physician and one of the leading authorities in the United States on evidence-based herbal medicine. He is the founder and director of Natural Products Research Consultants, Inc., and serves on the Advisory Board of the American Botanical Council and the President's Advisory Board of Bastyr University. This article is provided by Healthnotes for theBetterHealthStore. Copyright © 2001 Healthnotes, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
HOME PAGE | PRODUCTS | BRANDS | SALE | CONTACT Information presented at theBetterHealthStore.com is for educational purposes only; statements about products and health conditions have not been evaluated by the U.S. Food & Drug Administration. Copyright ©2001 theBetterHealthStore.com Inc. |